The liquid biopsy market is expanding rapidly, driven by advancements in precision medicine, non-invasive diagnostic methods, and growing demand for early cancer detection. This technology, which allows doctors to detect cancer and other diseases through blood samples instead of invasive tissue biopsies, is revolutionizing patient care by offering